Press release Luebeck, April 6th 2017 Today EUROIMMUN and Roche announced that they have entered into an option agreement under which Roche gains access to intellectual property in the field of Zika virus immunodiagnostics assigned to EUROIMMUN. In January 2016, EUROIMMUN became the first company in the world to launch antibody tests that are capable […]
In 2016, the number of whooping cough cases has reached a worrying record in Germany – 22,000 lab confirmed cases were reported to the Robert-Koch-Institute (RKI). In the previous year there were 14,000 cases and more than 1,500 patients have already been registered in 2017 (as of February 9th, 2017). Whooping cough is caused by
Earlier this year, EUROIMMUN announced the availability of the first serological test systems for diagnostics of Zika virus infections. The infectious disease had rapidly spread in Latin America, especially in Brazil, during the past year. Suspicion regarding a link between the virus infections and the increased rate of malformations of newborns’ heads (microcephaly) precipitated concerns
Press release Luebeck, 29th January 2016 EUROIMMUN AG, a manufacturer of test systems and instruments for medical diagnostics with headquarters in Luebeck, Germany, has developed the first complete test package worldwide for the serological detection of Zika virus infections. The ELISA and indirect immunofluorescence tests allow the determination of specific antibodies (IgM, IgG) against the
In May 2015, the first case of Zika virus (ZIKV) infection was reported in Brazil. To date, the infectious disease has been primarily present in Asia and Africa, but since the beginning of 2015 it has spread across the Americas. ZIKV is transmitted by the same mosquitoes (Aedes aegypti, Aedes albopictus) as the dengue and
